Documented traditional cardiovascular risk factors and mortality in non-ST-segment elevation myocardial infarction

American Heart Journal

Volumn 153, Issue 4, 2007, Pages 507-514

  Roe, Matthew T ^a   Halabi, Abdul R ^a   Mehta, Rajendra H ^a   Chen, Anita Y ^a   Kristin Newby, L ^a   Harrington, Robert A ^a   Smith Jr , Sidney C ^b   Ohman, E Magnus ^a   Gibler, W Brian ^c   Peterson, Eric D ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

^c UNIVERSITY OF CINCINNATI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CREATINE KINASE; TROPONIN I; TROPONIN T;

ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CLINICAL FEATURE; FEMALE; HEART INFARCTION; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; POPULATION RESEARCH; PRIORITY JOURNAL; REVASCULARIZATION; RISK FACTOR; ST SEGMENT ELEVATION; TREATMENT OUTCOME;

AGED; CARDIOVASCULAR DISEASES; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; RISK FACTORS;

EID: 33947303579     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2006.12.018     Document Type: Article

References (31)

1. Stamler J., Vaccaro O., Neaton J.D., et al. Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care 16 (1993) 434-444
2. Verschuren W.M., Jacobs D.R., Bloemberg B.P., et al. Serum total cholesterol and long-term coronary heart disease mortality in different cultures. Twenty-five-year follow-up of the seven countries study. JAMA 274 (1995) 131-136
3. Houterman S., Verschuren W.M., and Kromhout D. Smoking, blood pressure and serum cholesterol-effects on 20-year mortality. Epidemiology 14 (2003) 24-29
4. Cole J.H., Miller III J.I., Sperling L.S., et al. Long-term follow-up of coronary artery disease presenting in young adults. J Am Coll Cardiol 41 (2003) 521-528
5. American Stroke Association, and American Heart Association. Heart disease and stroke statistics-2005 update. Available at:. http://www.americanheart.org/statistics [Accessed January 4, 2005]
6. Khot U.N., Khot M.B., Bajzer C.T., et al. Prevalence of conventional risk factors in patients with coronary heart disease. JAMA 290 (2003) 898-904
7. Yusuf S., Hawken S., Ounpuu S., et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 364 (2004) 937-952
8. Roe M.T., Ohman E.M., Pollack Jr. C.V., et al. Changing the model of care for patients with acute coronary syndromes. Am Heart J 146 (2003) 605-612
9. Braunwald E., Antman E.M., Beasley J.W., et al. ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction-summary article: a report of the American College of Cardiology/American Heart Association task force on practice guidelines (Committee on the Management of Patients With Unstable Angina). J Am Coll Cardiol 40 (2002) 1366-1374
10. Cannon C.P., Battler A., Brindis R.G., et al. American College of Cardiology key data elements and definitions for measuring the clinical management and outcomes of patients with acute coronary syndromes. A report of the American College of Cardiology Task Force on Clinical Data Standards (Acute Coronary Syndromes Writing Committee). J Am Coll Cardiol 38 (2001) 2114-2130
11. Liang K.Y., and Zeger S.L. Longitudinal data analysis using generalized linear models. Biometrika 73 (1986) 13-22
12. Roe M.T., Harrington R.A., Prosper D.M., et al. Clinical and therapeutic profile of patients presenting with acute coronary syndromes who do not have significant coronary artery disease. The Platelet Glycoprotein IIb/IIIa in Unstable Angina: Receptor Suppression Using Integrilin Therapy (PURSUIT) Trial Investigators. Circulation 102 (2000) 1101-1106
13. Granger C.B., Goldberg R.J., Dabbous O., et al. Predictors of hospital mortality in the global registry of acute coronary events. Arch Intern Med 163 (2003) 2345-2353
14. Peterson E.D., Roe M.T., Mulgund J., et al. Association between hospital process performance and outcomes among patients with acute coronary syndromes. JAMA 295 (2006) 1912-1920
15. Mukherjee D., Fang J., Chetcuti S., et al. Impact of combination evidence-based medical therapy on mortality in patients with acute coronary syndromes. Circulation 109 (2004) 745-749
16. Allen L.A., O'Donnell C.J., Guigliano R.P., et al. Care concordant with guidelines predicts decreased long-term mortality in patients with unstable angina pectoris and non-ST-elevation myocardial infarction. Am J Cardiol 93 (2004) 1218-1222
17. Saito I., Folsom A.R., Brancati F.L., et al. Non-documented traditional risk factors for coronary heart disease incidence among persons with diabetes: the Atherosclerosis Risk in Communities (ARIC) Study. Ann Intern Med 133 (2000) 81-91
18. Greenland P., Knoll M.D., Stamler J., et al. Major risk factors as antecedents of fatal and nonfatal coronary heart disease events. JAMA 290 (2003) 891-897
19. Ridker P.M., Brown N.J., Vaughan D.E., et al. Established and emerging plasma biomarkers in the prediction of first atherothrombotic events. Circulation 109 Suppl IV (2004) IV6-IV19
20. Ridker P.M. Clinical application of C-reactive protein for cardiovascular disease detection and prevention. Circulation 107 (2003) 363-369
21. Lindmark E., Diderholm E., Wallentin L., et al. Relationship between interleukin 6 and mortality in patients with unstable coronary artery disease: effects of an early invasive strategy. JAMA 286 (2001) 2107-2113
22. Malik I., Danesh J., Whincup P., et al. Soluble adhesion molecules and prediction of coronary heart disease: a prospective study and meta-analysis. Lancet 358 (2001) 971-976
23. Zhang R., Brennan M.L., Fu X., et al. Association between myeloperoxidase levels and risk of coronary artery disease. JAMA 286 (2001) 2136-2142
24. Hamsten A., de Faire U., Walldius G., et al. Plasminogen activator inhibitor in plasma: risk factor for recurrent myocardial infarction. Lancet 2 (1987) 3-9
25. Moss A.J., Goldstein R.E., Marder V.J., et al. Thrombogenic factors and recurrent coronary events. Circulation 99 (1999) 2517-2522
26. Wald D.S., Law M., and Morris J.K. Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis. Br Med J 325 (2002) 1202
27. Lloyd-Jones D.M., Liu K., and Greenland P. Narrative review: assessment of C-reactive protein in risk prediction for cardiovascular disease. Ann Intern Med 145 (2006) 35-42
28. Potti A., Bild A., Dressman H.K., et al. Gene-expression patterns predict phenotypes of immune-mediated thrombosis. Blood 107 (2006) 1391-1396
29. Maguire P.B., Foy M., and Fitzgerald D.J. Using proteomics to identify potential therapeutic targets in platelets. Biochem Soc Trans 33 Pt 2 (2005) 409-412
30. Werner N., Kosiol S., Schiegl T., et al. Circulating endothelial progenitor cells and cardiovascular outcomes. N Engl J Med 353 (2005) 999-1007
31. Folsom A.R., Chambless L.E., and Ballantyne C.M. An assessment of incremental coronary risk prediction using C-reactive protein and other novel risk markers: The Atherosclerosis Risk in Communities Study. Arch Intern Med 166 (2006) 1368-1373